Log in to save to my catalogue

Rapamycin suppresses inflammation and increases the interaction between p65 and IκBα in rapamycin-in...

Rapamycin suppresses inflammation and increases the interaction between p65 and IκBα in rapamycin-in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2782155701

Rapamycin suppresses inflammation and increases the interaction between p65 and IκBα in rapamycin-induced fatty livers

About this item

Full title

Rapamycin suppresses inflammation and increases the interaction between p65 and IκBα in rapamycin-induced fatty livers

Publisher

United States: Public Library of Science

Journal title

PloS one, 2023-03, Vol.18 (3), p.e0281888-e0281888

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Rapamycin treatment significantly increases lifespan and ameliorates several aging-related diseases in mice, making it a potential anti-aging drug. However, there are several obvious side effects of rapamycin, which may limit the broad applications of this drug. Lipid metabolism disorders such as fatty liver and hyperlipidemia are some of those unw...

Alternative Titles

Full title

Rapamycin suppresses inflammation and increases the interaction between p65 and IκBα in rapamycin-induced fatty livers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2782155701

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2782155701

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0281888

How to access this item